Newsletter January 2024 No.219
Top News
On October 17, 2023, a special session of JPMA was held at the 10th Nikkei-FT Conference on Infectious Diseases. The theme of the session was "Toward the Establishment of a Drug Discovery Ecosystem in the Field of Infectious Diseases: A Year in Review and Future Initiatives," and based on the progress made since 2022, the issues and strategies necessary to make the drug discovery ecosystem in the field of infectious diseases sustainable were discussed from the perspective of industry, academia, and government.
Topics
- The 22nd JPMA Forum" was held.
- The 5th Japan-Korea Symposium on Regulation of Medical Products
- The 11th Japan-Taiwan Pharmaceutical Exchange Conference" was held.
- ICH Prague Meeting" was held
- Briefing on the Revision of the "Guidelines for the Preparation of Product Information Summaries, etc. for Ethical Drugs" Held
- The 40th Public Relations Seminar" held - SNS and Web Literacy Seminar
- The "2023 Drug Evaluation Committee Assembly" was held.
Breakthrough to Drug Loss -Aiming for Safe, Secure, and Well-Being Medicine and Society - Report on the Opening Ceremony, Keynote Speech, and Biopharmaceutical Committee Seminar at BioJapan 2023
Explanation
Policy Research Institute
From JPMA
At the Beginning of the Year 2024
